Formulation aspects on dermatological preparations and transdermal drug delivery systems
Junginger, H.E.
Acta Pharmaceutica Nordica 4(2): 117
1992
ISSN/ISBN: 1100-1801 PMID: 1388757 Document Number: 404714
Document emailed within 1 workday
Related Documents
Szabó, B.ás.; Hetényi, G.; Majoros, K.; Miszori, V.; Kállai, N.; Zelkó, R.án. 2011: Formulation aspects and ex-vivo examination of buccal drug delivery systems Acta Pharmaceutica Hungarica 81(4): 165-172Pfister, W.R.; Hsieh, D.S. 1990: Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations Medical Device Technology 1(6): 28-33
Xi, N.Z. 1984: Controlled-release drug delivery systems and sustained preparations Yao Xue Xue Bao 19(9): 715-719
Urquhart, J. 1984: Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology Bollettino Chimico Farmaceutico 123(4): 155-168
Foldvari, M.; Baca-Estrada, M.E.; He, Z.; Hu, J.; Attah-Poku, S.; King, M. 1999: Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha Biotechnology and Applied Biochemistry 30(2): 129-137
Csóka, G.; Pásztor, E.; Marton, S.; Zelkó, R.án.; Antal, I.; Klebovich, I. 2007: Formulation of thermoresponsive transdermal therapeutic systems using cellulose derivatives Acta Pharmaceutica Hungarica 77(2): 102-107
Csaba, N.; Alonso, M.J. 2014: 12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) Journal of Controlled Release: Official Journal of the Controlled Release Society 190: 53-54
Khurmi, N.S.; O'Hara, M.J.; Bowles, M.J.; Whittington, J.R.; Lahiri, A.; Raftery, E.B. 1986: Transmucosal and transdermal nitroglycerin delivery systems for prevention of chronic stable angina pectoris British Journal of Clinical Practice 40(5): 187-191
Zhang, J.-y.; Zhao, Y.-j.; Yang, X.-l. 2006: Design and manufacture of microneedles array for transdermal drug delivery Zhongguo Yi Liao Qi Xie Za Zhi 30(1): 33-38
Fang, J.Y.; Chen, S.S.; Wu, P.C.; Tsai, Y.H. 1999: Effect of adhesive and drug reservoir on in vitro transdermal delivery of nicotine Die Pharmazie 54(2): 154-155
Liu, J-ping.; Zhu, J-bi.; Chen, S-jun.; Zhao, X. 2006: Study on evaluation index of acupoint transdermal administration--drug delivery coefficient Zhongguo Zhen Jiu 26(7): 507-509
Kramar, M.; Giersch, K.H.; Schneider, H.T. 1987: Transdermal therapy of stable angina pectoris. Comparison of 2 different transdermal systems Fortschritte der Medizin 105(17): 340-342
Shader, R.I.; Greenblatt, D.J. 1997: It's in the bag: drug absorption by drug-delivery systems Journal of Clinical Psychopharmacology 17(5): 339-340
Raynaud, F. 1998: Novel drug delivery systems Idrugs: the Investigational Drugs Journal 1(4): 399-401
Hnatyszyn, H.J.; Kossovsky, N.; Gelman, A.; Sponsler, E. 1994: Drug delivery systems for the future PDA Journal of Pharmaceutical Science and Technology 48(5): 247-254
Iga, T. 1989: Injectable and implantable drug delivery systems Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1261-1267
Caixeta, A.; Abizaid, A.; Aoki, J.; Dangas, G.; Mehran, R. 2008: Future stent drug delivery systems Minerva Cardioangiologica 56(1): 155-166
Hogan, B. 2006: The role of filtration in drug delivery systems Medical Device Technology 17(5): 22-24
Rohan, L.Cencia.; Sassi, A.B. 2009: Vaginal drug delivery systems for HIV prevention Aaps Journal 11(1): 78-87
Donawa, M. 2000: Drug delivery systems: avoiding the pitfalls Medical Device Technology 11(6): 28-31